Close
Almac
Achema middle east

Drug Research

Biopharmaceutical Formulation Stability Solutions

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has fundamentally transformed therapeutic medicine, with protein-based therapeutics including monoclonal antibodies, fusion proteins, antibody-drug conjugates, and advanced biologic systems becoming cornerstones of treatment for cancer, autoimmune diseases, metabolic disorders, and numerous...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry confronts an enduring challenge where promising therapeutic molecules fail clinical translation due to inadequate bioavailability. Advanced drug delivery bioavailability enhancement has emerged as a critical enabler transforming compounds with poor...

Innovative Formulation Strategies for Poorly Soluble Drugs

The pharmaceutical industry confronts a formidable obstacle that threatens to derail promising therapeutic candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new chemical entities in development pipelines, creating fundamental challenges for drug absorption and bioavailability...

SAE Media Group Unveils Brochure for AI in Drug Discovery 2026 as Global Market Surges Toward $8.5B

SAE Media Group is proud to announce the release of the official brochure for AI in Drug Discovery 2026, taking place 9–10 March 2026 in London. The newly published agenda highlights how artificial intelligence is transforming pharmaceutical R&D, from...

Novartis-Argo $5.2 Licensing Deal for Heart Drugs

Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...

The Shift Towards Real-World Evidence Clinical Development

The fact remains that the pharmaceutical spectrum happens to stand on the edge of fundamental transformation as the real-world evidence clinical development methods go on to reshape how one gauges the therapeutic intervention. This kind of revolution happens to...

Evolution of Multi-Omic Integration in Precision Medicine

The convergence of genomics, proteomics, transcriptomics, metabolomics, and pathology data represents the most significant advancement in precision medicine since the completion of the Human Genome Project. This multi-omic data integration precision medicine approach promises to revolutionize healthcare by providing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »